Hartlon
Newark, US · 1 known investors
HARTLON manufactures a drug-eluting resorbable vascular stent that provides temporary radial support to arteries during disease treatment and dissolves after healing is complete, leaving the artery in its natural state.
Investors · 1
Competitors · 1
by search overlapCompanies competing with Hartlon for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Hartlon do?
- HARTLON manufactures a drug-eluting resorbable vascular stent that provides temporary radial support to arteries during disease treatment and dissolves after healing is complete, leaving the artery in its natural state.
- Who are Hartlon's investors?
- Hartlon's investors include The Innovation Space.
- Where is Hartlon headquartered?
- Hartlon is headquartered in Newark, US.